HOME >> BIOLOGY >> NEWS
Blocking neurodegeneration by radiation and bone marrow transfer prevents inherited glaucoma in mice

Bar Harbor, Maine In a discovery that could point to new treatments for a wide range of neurodegenerative diseases, Jackson Laboratory researchers have found that high-dose radiation and bone marrow transfer treatments on glaucoma-susceptible mice completely blocked the development of glaucoma, by preventing neurodegeneration.

Glaucomas are among the most common neurodegenerative diseases, and a leading cause of blindness in the United States. Many patients with glaucoma have high intraocular pressure (IOP), long believed to be a cause of the degeneration of the optic nerve and nerve cells in the retina that leads to vision loss. The standard treatment for glaucoma is reducing the intraocular pressure by medication or surgery.

However, researchers have also observed that some patients with elevated IOP do not develop optic nerve and retinal damage, while others do incur damage despite relatively normal IOP. "It's increasingly clear," says Dr. Simon W.M. John, leader of the Jackson Laboratory research team and a Howard Hughes Medical Institute Investigator, "that multiple mechanisms are at work in this disease."

John and researchers elsewhere have identified several genes associated with glaucomas. They have also developed inherited mouse glaucoma models that reliably develop glaucoma in mid-life. One of these models is the DBA/2J mouse.

The Jackson research team treated 5- to 8-week-old DBA/2J mice with a single, high dose of gamma radiation, together with bone marrow transfer.

When they examined the mice at 12-14 months--an age at which most DBA/2J mice have advanced glaucoma--the researchers were amazed to find that the vast majority of mice did not have glaucoma. There was no detectable loss of the retinal ganglion cells, which typically degenerate in glaucoma.

"It was very surprising and we had to be very careful," John said. "We repeated the experiment two more times with the same results."

The research p
'"/>

Contact: Joyce Peterson
joyce@jax.org
207-288-6058
Jackson Laboratory
10-Mar-2005


Page: 1 2

Related biology news :

1. Blocking beta1-integrin to treat cancer
2. Blocking a premature aging syndrome with anticancer drugs
3. Blocking blood vessels provides new option for large group of advanced lung cancer patients
4. Blocking COX-1 slows tumor growth in mice
5. Blocking PLK-1 to beat bladder cancer
6. Blocking cell signaling can stymie viral infections, study shows
7. Blocking cell suicide switch fails to stop prion damage in mouse brains
8. Early environmental exposure may accelerate age-related neurodegeneration
9. Enhanced environment restores memory in mice with neurodegeneration
10. Salk and Stanford teams join forces to reveal two paths of neurodegeneration
11. Transcription factor proteins role in cell death, neurodegeneration and schizophrenia

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/18/2019)... , ... December 17, 2019 , ... ... mitochondria, announced enrollment of first patients in its U.S. Phase 3 study VISTA-2 ... of SkQ1 compound in patients with moderate to severe Dry Eye Disease (DED). ...
(Date:12/18/2019)... ... 2019 , ... Intelligent.com, a trusted resource for online degree ... Degree Programs for 2020. The comprehensive research guide is based on an assessment ... based on curriculum quality, graduation rate, reputation, and post-graduate employment. , The ...
(Date:12/14/2019)... (PRWEB) , ... December 12, 2019 , ... ... products that protect or enhance crop yields, has appointed Jean Pougnier as chief ... and establish relationships with go-to-market partners and influencers that will position the company ...
Breaking Biology News(10 mins):
(Date:1/7/2020)... Conn. (PRWEB) , ... January 06, 2020 , ... ... today announced the second cohort of emerging biosciences ventures invited to participate in ... business education to develop fundable business plans and a professional network. All startups ...
(Date:12/31/2019)... , ... December 31, 2019 , ... At this year's ... that will be broadly focused on 3D cell culture , advanced imaging ... 3D cell culture assays for assessing steatosis , inflammation and fibrosis ...
(Date:12/27/2019)... TOWNSHIP, N.J. (PRWEB) , ... December 27, 2019 ... ... of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device ... calendar year under new management . Following acquisition by CLJ Holdings in ...
(Date:12/23/2019)... ... December 23, 2019 , ... Leak Detection Associates, the leading ... Medical Device Industries, is excited to announce that it will be a contributing ... Closure Integrity Testing Basic Training Course . Held in conjunction with PDA Europe’s ...
Breaking Biology Technology:
Cached News: